Literature DB >> 7560197

Simple method for quantifying viable bacterial numbers in sputum.

A Pye1, R A Stockley, S L Hill.   

Abstract

AIMS: To establish a simple method of quantitative culture for determining the viable bacterial numbers present in expectorated sputum samples.
METHODS: Sputum samples were homogenised with dithiothreitol, sterile saline or glass beads to determine which method recovered the greatest number of viable bacteria. Culture broths were also incubated with dithiothreitol and sampled over time to determine its effect on bacterial viability. Sputum samples homogenised with dithiothreitol were diluted in sterile saline and sampled using either standard bacteriological loops or a precision pipette to determine which method resulted in the least variation.
RESULTS: Homogenisation of sputum using dithiothreitol increased the recovery of viable bacteria compared with sterile glass beads and/or saline, with no apparent effect on bacterial viability when incubated with culture broths. By inoculating agar plates with 10(-3), 10(-4) and 10(-5) dilutions of the homogenised sputum sample, all potential pathogens could easily be identified. A 10 microliter sample volume dispensed by precision pipette and spread with a "hockey stick" resulted in the least variation between plates (less than 16%) and an even distribution of bacterial colonies. Numbers of viable bacteria recovered from different aliquots of individual sputum samples were generally of the same order of magnitude.
CONCLUSIONS: This method represents a relatively quick and simple technique for accurately quantifying viable bacteria present in sputum samples. The use of a small portion appears to be representative of the sample as a whole.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560197      PMCID: PMC502797          DOI: 10.1136/jcp.48.8.719

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Gram stain and culture of morning and 24 h sputum in the diagnosis of bacterial exacerbation of chronic bronchitis: a dogma disputed.

Authors:  T C Medici; A von Graevenitz; H Shang; E Böhni; M Wall
Journal:  Eur Respir J       Date:  1988-12       Impact factor: 16.671

2.  Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation.

Authors:  S L Hill; H M Morrison; D Burnett; R A Stockley
Journal:  Thorax       Date:  1986-07       Impact factor: 9.139

3.  The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage.

Authors:  J A Pang; A Cheng; H S Chan; D Poon; G French
Journal:  Am Rev Respir Dis       Date:  1989-01

Review 4.  Chronic bronchitis: the antiproteinase/proteinase balance and the effect of infection and corticosteroids.

Authors:  R A Stockley
Journal:  Clin Chest Med       Date:  1988-12       Impact factor: 2.878

5.  Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state.

Authors:  R A Stockley; S L Hill; H M Morrison
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

6.  Accuracy of calibrated-loop transfer.

Authors:  A C Albers; R D Fletcher
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

Review 7.  Rational parameters for antibiotic therapy in patients with cystic fibrosis.

Authors:  J R Govan; C Doherty; S Glass
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

8.  Selective media for the quantitation of bacteria in cystic fibrosis sputum.

Authors:  K Wong; M C Roberts; L Owens; M Fife; A L Smith
Journal:  J Med Microbiol       Date:  1984-04       Impact factor: 2.472

9.  Simple method of monitoring colonising microbial load in chronic bronchial sepsis: pilot comparison of reduction in colonising microbial load with antibiotics given intermittently and continuously.

Authors:  D C Currie; E Higgs; S Metcalfe; D E Roberts; P J Cole
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

10.  Bacterial colonisation of the respiratory tract in chronic bronchitis.

Authors:  H L Butt; R L Clancy; A W Cripps; K Murree-Allen; N A Saunders; D C Sutherland; M J Hensley
Journal:  Aust N Z J Med       Date:  1990-02
View more
  16 in total

1.  Immune response to Haemophilus parainfluenzae in patients with chronic obstructive lung disease.

Authors:  J L Mitchell; S L Hill
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.

Authors:  S Gompertz; D L Bayley; S L Hill; R A Stockley
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

3.  2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent Pseudomonas aeruginosa burden in adults with cystic fibrosis.

Authors:  Nur Masirah M Zain; Karmel Webb; Iain Stewart; Nigel Halliday; David A Barrett; Edward F Nash; Joanna L Whitehouse; David Honeybourne; Alan R Smyth; Douglas L Forrester; Alan J Knox; Paul Williams; Andrew Fogarty; Miguel Cámara; Kenneth D Bruce; Helen L Barr
Journal:  J Med Microbiol       Date:  2021-10       Impact factor: 3.196

4.  Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis.

Authors:  A J White; S Gompertz; D L Bayley; S L Hill; C O'Brien; I Unsal; R A Stockley
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

5.  Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.

Authors:  Mona Bafadhel; Susan McKenna; Sarah Terry; Vijay Mistry; Mitesh Pancholi; Per Venge; David A Lomas; Michael R Barer; Sebastian L Johnston; Ian D Pavord; Christopher E Brightling
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

6.  Bacteria in sputum of stable severe asthma and increased airway wall thickness.

Authors:  Qingling Zhang; Rowland Illing; Christopher K Hui; Kate Downey; Denis Carr; Martin Stearn; Khalid Alshafi; Andrew Menzies-Gow; Nanshan Zhong; Kian Fan Chung
Journal:  Respir Res       Date:  2012-04-18

7.  The role of CT scanning in multidimensional phenotyping of COPD.

Authors:  Mona Bafadhel; Imran Umar; Sumit Gupta; J Vimal Raj; Dhiraj D Vara; James J Entwisle; Ian D Pavord; Christopher E Brightling; Salman Siddiqui
Journal:  Chest       Date:  2011-03-31       Impact factor: 9.410

8.  Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study.

Authors:  David G Parr; Andrew J White; Darren L Bayley; Peter J Guest; Robert A Stockley
Journal:  Respir Res       Date:  2006-11-18

9.  Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.

Authors:  Mona Bafadhel; Koirobi Haldar; Bethan Barker; Hemu Patel; Vijay Mistry; Michael R Barer; Ian D Pavord; Christopher E Brightling
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-09

10.  Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.

Authors:  Roshan Siva; Mona Bafadhel; William Monteiro; Christopher E Brightling; Ian D Pavord
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.